We describe our experience with ascorbic acid in the treatment of chronic refractory ITP. Nine patients, 5 males and 4 females aged 27-74 years, 4 of whom were previously splenectomized, received the drug at a daily dose of 2 grams. After 2-12 months (median 4) of treatment, a partial response was observed in only one patient, while no response was registered in the other eight. Our data, analyzed together with those of the literature, allow us to conclude that ascorbic acid may not be considered a drug of interest in the treatment of chronic refractory ITP.

Vianelli N., Gugliotta L., Gianni L., Belmonte M.M., Catani L., Tura S. (1992). Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP). HAEMATOLOGICA, 77(1), 92-93.

Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP)

Catani L.;
1992

Abstract

We describe our experience with ascorbic acid in the treatment of chronic refractory ITP. Nine patients, 5 males and 4 females aged 27-74 years, 4 of whom were previously splenectomized, received the drug at a daily dose of 2 grams. After 2-12 months (median 4) of treatment, a partial response was observed in only one patient, while no response was registered in the other eight. Our data, analyzed together with those of the literature, allow us to conclude that ascorbic acid may not be considered a drug of interest in the treatment of chronic refractory ITP.
1992
Vianelli N., Gugliotta L., Gianni L., Belmonte M.M., Catani L., Tura S. (1992). Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP). HAEMATOLOGICA, 77(1), 92-93.
Vianelli N.; Gugliotta L.; Gianni L.; Belmonte M.M.; Catani L.; Tura S.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/915172
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact